Product Information
SUMATRIPTAN 6 MG/0.5 ML AUTOINJ is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $62.9652 per ML under NDC 55111069312. Its NADAC has been published 636 times since May 28, 2014.
FDA first approved this application on Jan 29, 2014. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
6 mg/.5mL
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
55111069312
Classification
Generic
Dosage Form
INJECTION
Route
SUBCUTANEOUS
Effective Date
7/22/2026
Active Ingredients
SUMATRIPTAN SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA090495FDA Approved
1/29/2014
TE Code
AB
On Market Since
2/24/2014
Pharmacological Classes
Price Statistics
The NADAC for SUMATRIPTAN 6 MG/0.5 ML AUTOINJ has been published 636 times since May 28, 2014, and over the history we have for it it has declined 50.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $62.9652 per ML |
|---|---|
| All-time high | $153.0292 (Jan 11, 2017) |
| All-time low | $46.6942 (May 22, 2024) |
| 52-week high | $75.8160 |
| 52-week low | $62.9652 |
| Median price | $83.4202 |
| Average price | $94.2575 |
| Largest weekly change | +61.1% (Jun 19, 2024) |
| Weeks tracked | 636 |
| Tracking since | May 28, 2014 |
1W
N/A
1M
0.0%
3M
-9.5%
6M
-11.3%
1Y
-12.8%
3Y
+16.7%
5Y
-15.0%
All
-50.6%
Last surveyed Jul 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 76% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of SUMATRIPTAN 6 MG/0.5 ML AUTOINJ?
The current National Average Drug Acquisition Cost (NADAC) for SUMATRIPTAN 6 MG/0.5 ML AUTOINJ, manufactured by Dr. Reddy's Laboratories Inc., is $62.9652 per ML (NDC 55111069312), effective Jul 29, 2026.
How has the price of SUMATRIPTAN 6 MG/0.5 ML AUTOINJ changed over time?
Over the history we have for it, the NADAC for SUMATRIPTAN 6 MG/0.5 ML AUTOINJ has declined 50.6%. It has been tracked across 636 weekly CMS publications since May 28, 2014.
What are the highest and lowest recorded NADAC prices for SUMATRIPTAN 6 MG/0.5 ML AUTOINJ?
Since May 28, 2014, the NADAC for SUMATRIPTAN 6 MG/0.5 ML AUTOINJ has ranged from a low of $46.6942 (May 22, 2024) to a high of $153.0292 (Jan 11, 2017), with a median of $83.4202 per ML.
Are there cheaper alternatives to SUMATRIPTAN 6 MG/0.5 ML AUTOINJ?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SUMATRIPTAN 6 MG/0.5 ML VIAL, is $15.0000 per ML — about 76% below SUMATRIPTAN 6 MG/0.5 ML AUTOINJ.
Who manufactures SUMATRIPTAN 6 MG/0.5 ML AUTOINJ?
SUMATRIPTAN 6 MG/0.5 ML AUTOINJ (NDC 55111069312) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.